Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

NRIs seek tax parity with FIIs on capital gains in stocks
Describing Non-Resident Indians as a "national resource," a grouping of NRIs led by Hindujas has asked the government for tax parity with Foreign Institutional Investors on short-term gains in the stock market.

Tata Motors to launch Manza sedan next week
Tata Motors, India’s biggest auto company, will look to strengthen its presence in the sedan segment with the launch of an all-new mid range sedan, Manza, next week. It will be priced in the range of Rs 5-7 lakh. The Manza is basically the sedan version of the indigenous hatchback, Indica Vista, launched by the company in August last year. The car is aimed at arresting the company’s dwindling performance in the sedan category.

News of the day

IMF welcomes Chinese decision to invest $50 bn
The International Monetary Fund has welcomed the Chinese decision to invest $50 billion in notes issued by IMF which would help in addressing the issues of the global financial crisis in third world countries.
Online Business

Johnson & Johnson Q2 profit dips to $3.2 bn

Consumer healthcare products maker Johnson & Johnson today reported a 3.6 per cent drop in profit at $3.20 billion for the three months ended June, mainly on account of overall fall in sales. - Goldman Q2 profit surges 65% to $3.44 bn - India can become a global pharma innovation hub: experts The company had a profit of $3.32 billion in the second quarter of 2008, it said in a statement. In the same quarter, sales declined to $15.23 billion as against $16.45 billion in the corresponding period a year ago. "The second quarter of 2008 included an after-tax in-process research and development charge of $40 million," the statement said. Sales in pharmaceutical segment plunged 13.3 per cent to $5.49 billion. In the consumer segment, sales fell 4.5 per cent to $3.9 billion worldwide in the second quarter, while medical and diagnostics sales declined 3.1 per cent to $5.88 billion. "I am proud of the accomplishments of our people in continuing to deliver very solid operational results in light of the significant impacts of patent expirations and the economic environment," Johnson & Johnson Chairman and Chief Executive Officer William C Weldon said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009